M28 Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$755K Sell
210,871
-174,809
-45% -$695K 1.4% 7
2025
Q4
$1.35M Hold
385,680
0.98% 7
2025
Q3
$1.26M Hold
385,680
1.85% 7
2025
Q2
$945K Hold
385,680
1.61% 9
2025
Q1
$2.57M Hold
385,680
3.53% 5
2024
Q4
$4.85M Hold
385,680
4.76% 3
2024
Q3
$7.12M Hold
385,680
7.83% 3
2024
Q2
$8.3M Hold
385,680
10.76% 3
2024
Q1
$10.4M Sell
385,680
-137,600
-26% -$3.91M 7.68% 4
2023
Q4
$15.7M Hold
523,280
12.99% 3
2023
Q3
$10.7M Sell
523,280
-107,100
-17% -$1.95M 12.3% 3
2023
Q2
$12.5M Sell
630,380
-91,700
-13% -$1.85M 16.55% 2
2023
Q1
$12.4M Hold
722,080
13.99% 2
2022
Q4
$14.1M Buy
722,080
+56,200
+8% +$1.03M 13.47% 2
2022
Q3
$10.6M Sell
665,880
-50,000
-7% -$780K 11.09% 3
2022
Q2
$9.85M Hold
715,880
11.04% 3
2022
Q1
$11.4M Buy
715,880
+220,600
+45% +$3.81M 10.44% 3
2021
Q4
$10.8M Buy
+495,280
New +$13.5M 8.44% 5

Other funds holding RCKT